Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Genoscience's first-in-class autophagy inhibitor GNS-561

Nov. 18, 2015

Phase I results for FPA-008 in RA

Nov. 18, 2015

First-in-patient data for anti-fractalkine MAb E-6011 in RA

Nov. 18, 2015

ProMetic reveals agent under development for diabetic nephropathy

Nov. 18, 2015

Tolerability of pevonedistat with docetaxel, paclitaxel/carboplatin or gemcitabine

Nov. 18, 2015

Long-term data for olokizumab in rheumatoid arthritis

Nov. 18, 2015

Promising results of a novel therapeutic approach to polycystic ovary syndrome

Nov. 17, 2015

Nimbus' potent TYK2 inhibitor NDI-031301

Nov. 17, 2015

Otsuka's OPB-111077 tested in subjects with advanced cancer

Nov. 17, 2015

WNT-974, a first-in-class porcupine inhibitor in advanced solid tumors

Nov. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...